From gene-to-structure, our team of Structural Biologists and Biophysicists are ready to tackle the hardest projects in our state-of-the-art facilities.
We define best-in-class practices for animal care to deliver superior study outcomes. Standard or custom models? We have you covered.
Welcome to Ichor!
We strive for people to live longer, healthier lives.
To make this vision a reality, we provide premium laboratory research services to biotechnology and pharmaceutical companies. At Ichor, we are dedicated to changing the world because we believe we can.
Welcome to Ichor.
Kinetics of the multitasking high-affinity Win binding site of WDR5 in restricted and unrestricted conditions (2021)
Using real-time binding measurements in a high-throughput setting, we identified the kinetic fingerprint of transient associations between WDR5 and 14-residue WDR5 interaction (Win) motif peptides of each SET1 protein (SET1Win).
SIRT6 is Responsible for More Efficient DNA Double-Strand Break Repair in Long-Lived Species (2020)
We dissected the molecular differences between a weak and a strong SIRT6 protein and identified five amino acid residues that are fully responsible for their differential activities, demonstrating that DSB repair and SIRT6 have been optimized during the evolution of longevity.
Ichor Publishes Article Unraveling Evolutionary Mechanisms of Phase Separation Proteins in Extreme Microorganisms
Ichor Publishes Article Unraveling Evolutionary Mechanisms of Phase Separation Proteins in Extreme Microorganisms Lafayette, N.Y. – September 8, 2022 – Ichor Life
LENTO BIO RAISES $680,000 IN OVERSUBSCRIBED SEED ROUND LED BY ICHOR LIFE SCIENCES￼
LENTO BIO RAISES $680,000 IN OVERSUBSCRIBED SEED ROUND LED BY ICHOR LIFE SCIENCES Potsdam, N.Y. – September 6, 2022 – Lento Bio,
ICHOR LIFE SCIENCES INVESTS $1.5 MILLION IN MITOCHEM THERAPEUTICS FOR OCULAR AGING DISEASE RESEARCH
ICHOR LIFE SCIENCES INVESTS $1.5 MILLION IN MITOCHEM THERAPEUTICS FOR OCULAR AGING DISEASE RESEARCH LaFayette, N.Y. – August 11, 2022 – Ichor